Accentia Chronic Sinusitis Candidate Fails Phase III Clinical Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Disappointing trial data for intranasal lavage formulation sends Florida firm’s stock price tumbling by more than two-thirds.